Merit Financial Group »

Allogene Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $32k 13k 2.44

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Us Gwt (IUSG)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Us Vlu (IUSV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Mega Cap Val Etf (MGV)
Spdr Series Trust State Street Spd (SPTI)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Blackrock Etf Trust Ishares Intl Ctr (CORO)

View all positions for Merit Financial Group

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Vanguard Capital Management
Patient Square Capital
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Two Sigma Investments
Candriam Luxembourg S.C.A.
Wildcat Capital Management
Two Sigma Advisers

View all funds holding Allogene Therapeutics